Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections

Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections

10.1001/jamanetworkopen.2022.5750

Saved in:
Bibliographic Details
Main Authors: Park, Minah, Tan, Kelvin Bryan, Vasoo, Shawn, Dickens, Borame L, Lye, David, Cook, Alex R
Other Authors: DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format: Letter
Language:English
Published: AMER MEDICAL ASSOC 2023
Subjects:
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
Online Access:https://scholarbank.nus.edu.sg/handle/10635/242820
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
Description
Summary:10.1001/jamanetworkopen.2022.5750

Similar Items